Disorders due to substance use, unspecified

Sibling codes

• 6C40 – Disorders due to use of alcohol
• 6C41 – Disorders due to use of cannabis
• 6C42 – Disorders due to use of synthetic cannabinoids
• 6C43 – Disorders due to use of opioids
• 6C44 – Disorders due to use of sedatives, hypnotics or anxiolytics
• 6C45 – Disorders due to use of cocaine
• 6C46 – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
• 6C47 – Disorders due to use of synthetic cathinones
• 6C48 – Disorders due to use of caffeine
• 6C49 – Disorders due to use of hallucinogens
• 6C4A – Disorders due to use of nicotine
• 6C4B – Disorders due to use of volatile inhalants
• 6C4C – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
• 6C4D – Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
• 6C4E – Disorders due to use of other specified psychoactive substances, including medications
• 6C4F – Disorders due to use of multiple specified psychoactive substances, including medications
• 6C4G – Disorders due to use of unknown or unspecified psychoactive substances
• 6C4H – Disorders due to use of non-psychoactive substances
• 6C4Y – Other specified disorders due to substance use

Foundation entity

Disorders due to substance use – http://id.who.int/icd/entity/590211325